Abstract: ObjectiveTo compare the effect of Shengxuening tablet and capsule polysaccharideiron complex on anemia in peritoneal dialysis patients. MethodsA total of 60 peritoneal dialysis patients with anemia were randomly divided into Lifeineng group and Shengxuening tablet group. Hemoglobin， hematocrit， C reactive protein and other indicators were detected before treatment and each month after the treatment. ResultsBefore treatment， there was no significant difference between two groups. The levels of Hb and Hct were significantly increased after 3 month's treatment in both groups， however， there was no significant difference between two groups. After 9 month's treatment， the use of erythropoientin was significantly reduced in both groups， however， there was no significant difference between two groups. Shengxuening had significantly less adverse reaction of digestive tract and excessively rise of Hb than Lifeineng. ConclusionBoth oral iron and Shengxuening tablet can effectively improve the iron deficiency，anemia and reduce the use of erythropoientin in patients with peritoneal dialysis. Shengxuening has significantly less adverse reaction of digestive tract and excessively rise of Hb than Lifeineng.

Key words: anemia, irondeficiency, peritoneal dialysis, continuous ambulatory, recombinant human erythropoietin